NHS hepatitis C antibody testing guidance for community pharmacy
Summarised information on offering HCV antibody testing in community pharmacy
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
Educational resources
Management of hepatic encephalopathy in primary care
This management algorithm has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
View TARGAXAN® (rifaximin-α) prescribing and adverse event reporting information
UK-HEP-XIF-2100040 October 2021
The second in a series of half-day virtual events focusing on practical approaches to management of gastrointestinal disorders and iron deficiency
Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines. Promotional information regarding Norgine Pharmaceutical Limited products will be presented during these webinars.
UK-COR-NP-2100090
Date of preparation: October 2021
Half-day virtual event focusing on practical approaches to management of gastrointestinal disorders and iron deficiency
Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines.
UK-COR-NP-2100043
Date of preparation: July 2021